Harvard Study Finally Admits Drug Prices Are High Because Govt Grants Big Pharma A Monopoly [View all]

[workinclasszero]

Harvard Study Finally Admits Drug Prices Are High Because Govt Grants Big Pharma A Monopoly
BY REALITIES WATCH · AUGUST 28, 2016 By Matt Agorist

In what can only be described as paradigm-shattering research on drug prices, the Journal of the American Medical Association has officially recognized why drug prices skyrocket in America. Big pharma is granted a monopoly by the state which effectively eliminates their competition and allows them to charge any price they want — so they do.

A glaring example of the staggering discrepancies in American drug prices can be seen in the remarkable drug for Hep C, sofosbuvir. Sofosbuvir boasts a near miraculous cure rate of 84-96% for Hep C.

However, the American version of the drug Solvaldi by Gilead, which has an FDA-granted monopoly protecting it, will cost patients a mountainous $84,000.

In India, however, Gilead has to compete in a free market. Competitors, of which there a many, using the older, much cheaper, and equally effective drug, have driven the price down to a mere $4 a pill. This makes the total cost of curing Hepatitis C in India’s free market — $336.

https://realitieswatch.com/harvard-study-finally-admits-drug-prices-high-govt-grants-big-pharma-monopoly/